Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

KEPRO Extends Use of InterQual to Support Clinical Excellence in Utilization and Quality Reviews

KEPRO (Keystone Peer Review Organization, Inc.) has signed a long-term agreement to continue its use of InterQual® for utilization and quality review across its state Medicaid contracts, Medicare reviews, and other commercial lines. Specifically, KEPRO has renewed its license for all of the InterQual Level of Care, Behavioral Health, and Care Planning Criteria.

McKesson Corporation to Present at the Leerink Partners 5th Annual Global Healthcare Conference

McKesson Corporation (NYSE:MCK) today announced that James Beer, executive vice president and chief financial officer, will present at the Leerink Partners 5th Annual Global Healthcare Conference in New York.

ptum and Availity Partner to Improve Health Insurance Claims Submission Process for the Benefit of Care Professionals, Consumers and Health Plans

Advances in completeness and accuracy expected to reduce the number of claims-processing errors and appeals, improve care provider and patient experiences, avoid unnecessary costsAvaility will implement Optum’s Advanced Claim Editing (ACE) solution into its Availity Health Information Network; Optum will use Availity’s network to connect to commercial and government health plans nationwide

Stereotaxis and Philips Extend Development Collaboration to Interface Latest Systems

ST. LOUIS and BEST, The Netherlands, Jan. 26, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS) today announced Stereotaxis and Philips have signed an addendum pursuant to their existing Development and Cooperation Agreement to facilitate development of a new interface between each company’s most advanced systems for electrophysiology (EP) and interventional cardiology procedures. The new interface will enable interoperability of Stereotaxis’ Niobe® ES remote magnetic navigation system with the latest version of Philips’ cardiovascular X-ray system, Allura Xper FD10*. This new interface is expected to be available in major global markets in 2016.

Leica Biosystems and Advanced Cell Diagnostics Partner to Develop and Commercialize RNAscope-based Diagnostic and Companion Diagnostic Tests

NEWCASTLE UPON TYNE, UK and HAYWARD, CALIFORNIA, USA, January 26, 2016.Leica Biosystems, a global leader in anatomic pathology solutions and workflow automation, and Advanced Cell Diagnostics, Inc. (ACD), a world leader in RNA biomarker analysis for precision medicine, today announced a comprehensive partnership to develop and commercialize tissue-based diagnostic tests based on ACD's RNAscope in situ hybridization (ISH) assays on Leica Biosystems' BOND clinical advanced staining instruments. The agreement supports Leica Biosystems' development and commercialization of fully automated RNAscope-based companion diagnostic (CDx) tests in partnership with biopharmaceutical companies.

Study: No one spends more on healthcare than the U.S. government

The U.S. government spends more money on healthcare than any other nation in the world, including countries with universal healthcare programs such as Canada and the U.K., according to a study published online Jan. 21 in the American Journal of Public Health.

Learn about the revamped eCQI Resource Center

The Centers for Medicare & Medicaid Services has reintroduced its eCQI Resource Center, which serves as a one-stop shop for the most current resources to support electronic clinical quality improvement.

California hospital pays more than $3.2 million to settle allegations

A hospital in Oceanside, Calif., agreed to pay more than $3.2 million to settle claims it violated laws and Medicare’s prohibition on having an illegal financial relationship with referring physicians.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.